• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测根治性切除术后无大血管侵犯的肝细胞癌早期复发的术前和术后列线图。

Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection.

机构信息

Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.

Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, China.

出版信息

BMC Surg. 2022 Jun 17;22(1):233. doi: 10.1186/s12893-022-01682-0.

DOI:10.1186/s12893-022-01682-0
PMID:35715787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9205542/
Abstract

BACKGROUND

Postoperative early recurrence (ER) is a major obstacle to long-term survival after curative liver resection (LR) in patients with hepatocellular carcinoma (HCC). This study aimed to establish preoperative and postoperative nomograms to predict ER in HCC without macrovascular invasion.

METHODS

Patients who underwent curative LR for HCC between January 2012 and December 2016 were divided into training and internal prospective validation cohorts. Nomograms were constructed based on independent risk factors derived from the multivariate logistic regression analyses in the training cohort. The predictive performances of the nomograms were validated using the internal prospective validation cohort.

RESULTS

In total, 698 patients fulfilled the eligibility criteria. Among them, 265 of 482 patients (55.0%) in the training cohort and 120 of 216 (55.6%) patients in the validation cohort developed ER. The preoperative risk factors associated with ER were age, alpha-fetoprotein, tumor diameter, and tumor number, and the postoperative risk factors associated with ER were age, tumor diameter, tumor number, microvascular invasion, and differentiation. The pre- and postoperative nomograms based on these factors showed good accuracy, with concordance indices of 0.712 and 0.850 in the training cohort, respectively, and 0.754 and 0.857 in the validation cohort, respectively. The calibration curves showed optimal agreement between the predictions by the nomograms and actual observations. The area under the receiver operating characteristic curves of the pre- and postoperative nomograms were 0.721 and 0.848 in the training cohort, respectively, and 0.754 and 0.844 in the validation cohort, respectively.

CONCLUSIONS

The nomograms constructed in this study showed good performance in predicting ER for HCC without macrovascular invasion before and after surgery. These nomograms would be helpful for doctors when determining treatments and selecting patients for regular surveillance or administration of adjuvant therapies.

摘要

背景

术后早期复发(ER)是肝癌患者根治性肝切除(LR)后长期生存的主要障碍。本研究旨在建立预测无大血管侵犯的 HCC 患者 ER 的术前和术后列线图。

方法

2012 年 1 月至 2016 年 12 月期间,对接受根治性 LR 治疗 HCC 的患者进行了回顾性分析,将患者分为训练队列和内部前瞻性验证队列。基于训练队列中多变量逻辑回归分析得出的独立危险因素,建立了列线图。使用内部前瞻性验证队列验证了列线图的预测性能。

结果

共纳入 698 例符合条件的患者,其中训练队列 482 例患者中有 265 例(55.0%),验证队列 216 例患者中有 120 例(55.6%)发生 ER。与 ER 相关的术前危险因素包括年龄、甲胎蛋白、肿瘤直径和肿瘤数量,与 ER 相关的术后危险因素包括年龄、肿瘤直径、肿瘤数量、微血管侵犯和分化程度。基于这些因素建立的术前和术后列线图具有较好的准确性,在训练队列中的一致性指数分别为 0.712 和 0.850,在验证队列中的一致性指数分别为 0.754 和 0.857。校准曲线显示列线图预测值与实际观察值之间具有最佳一致性。训练队列中术前和术后列线图的受试者工作特征曲线下面积分别为 0.721 和 0.848,验证队列中分别为 0.754 和 0.844。

结论

本研究建立的列线图在预测无大血管侵犯的 HCC 患者术前和术后 ER 方面具有良好的性能。这些列线图将有助于医生在确定治疗方案和选择患者进行常规监测或辅助治疗时提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e131/9206318/a8a99ee08438/12893_2022_1682_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e131/9206318/d979dc5d0cce/12893_2022_1682_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e131/9206318/2a3eb946587c/12893_2022_1682_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e131/9206318/a8a99ee08438/12893_2022_1682_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e131/9206318/d979dc5d0cce/12893_2022_1682_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e131/9206318/2a3eb946587c/12893_2022_1682_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e131/9206318/a8a99ee08438/12893_2022_1682_Fig3_HTML.jpg

相似文献

1
Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection.预测根治性切除术后无大血管侵犯的肝细胞癌早期复发的术前和术后列线图。
BMC Surg. 2022 Jun 17;22(1):233. doi: 10.1186/s12893-022-01682-0.
2
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.米兰标准范围内乙型肝炎病毒相关性肝细胞癌微血管侵犯风险的术前预测列线图。
JAMA Surg. 2016 Apr;151(4):356-63. doi: 10.1001/jamasurg.2015.4257.
3
Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.新型模型预测乙型肝炎病毒相关≤10cm 单发肝细胞癌且无门静脉癌栓患者的术后复发和总生存期。
Oncologist. 2020 Oct;25(10):e1552-e1561. doi: 10.1634/theoncologist.2019-0766. Epub 2020 Aug 6.
4
[The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].基于Ishak炎症评分的列线图对肝细胞癌根治性切除术后复发的研究
Zhonghua Wai Ke Za Zhi. 2018 Feb 1;56(2):124-129. doi: 10.3760/cma.j.issn.0529-5815.2018.02.009.
5
Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.多机构验证新型模型预测巨大肝细胞癌患者预后的价值。
Int J Cancer. 2021 Jul 1;149(1):127-138. doi: 10.1002/ijc.33516. Epub 2021 Feb 27.
6
Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.预后列线图对根治性切除术后无门静脉肿瘤血栓形成的肝细胞癌患者的生存情况进行分层。
Oncologist. 2017 May;22(5):561-569. doi: 10.1634/theoncologist.2016-0231. Epub 2017 Apr 24.
7
New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.新的列线图可预测术前血清甲胎蛋白阴性且接受根治性切除的肝细胞癌患者的复发情况。
J Surg Oncol. 2018 Jun;117(7):1540-1547. doi: 10.1002/jso.25046. Epub 2018 Mar 24.
8
Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy.肝癌患者手术后极早期预后列线图和结局风险分类。
Eur J Surg Oncol. 2021 Mar;47(3 Pt B):681-689. doi: 10.1016/j.ejso.2020.10.039. Epub 2020 Oct 31.
9
Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.根治性肝切除术后术前全身免疫细胞对肝细胞癌预后价值的比较和验证。
Cancer Med. 2018 Apr;7(4):1170-1182. doi: 10.1002/cam4.1424. Epub 2018 Mar 13.
10
Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.用于预测肝细胞癌根治性肝切除术后复发和生存的预后列线图。
Ann Surg. 2015 May;261(5):939-46. doi: 10.1097/SLA.0000000000000747.

引用本文的文献

1
Construction of a 2.5D Deep Learning Model for Predicting Early Postoperative Recurrence of Hepatocellular Carcinoma Using Multi-View and Multi-Phase CT Images.基于多视图和多期CT图像构建2.5D深度学习模型预测肝细胞癌术后早期复发
J Hepatocell Carcinoma. 2024 Nov 16;11:2223-2239. doi: 10.2147/JHC.S493478. eCollection 2024.
2
Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors.肝细胞癌的宏观特征:一个未被充分利用的预后因素来源
J Hepatocell Carcinoma. 2024 Apr 6;11:707-719. doi: 10.2147/JHC.S447848. eCollection 2024.
3
Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives.

本文引用的文献

1
Screening, Surveillance, and Management of Hepatocellular Carcinoma During the COVID-19 Pandemic: a Narrative Review.在 COVID-19 大流行期间肝细胞癌的筛查、监测和管理:叙述性综述。
J Gastrointest Cancer. 2023 Jun;54(2):408-419. doi: 10.1007/s12029-022-00830-2. Epub 2022 May 2.
2
Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation.HBV-HDV 共感染对活体肝移植后 HBV-HCC 再发的影响。
Hepatol Int. 2020 Sep;14(5):869-880. doi: 10.1007/s12072-020-10085-3. Epub 2020 Sep 7.
3
Liver Transplantation for Hepatocellular Carcinoma: Malatya Experience and Proposals for Expanded Criteria.
肝切除术后及热消融后肝细胞癌复发的管理:现状与未来展望
Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):71-88. doi: 10.21037/hbsn-22-579. Epub 2023 Jun 19.
4
Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction.革新肝细胞癌监测:利用超声造影和血清学指标预测术后早期复发。
Medicine (Baltimore). 2023 Sep 1;102(35):e34937. doi: 10.1097/MD.0000000000034937.
5
Development and validation of a survival prediction model for 113,239 patients with colon cancer: a retrospective cohort study.113239例结肠癌患者生存预测模型的开发与验证:一项回顾性队列研究
J Gastrointest Oncol. 2022 Oct;13(5):2393-2405. doi: 10.21037/jgo-22-878.
6
Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis.新型术后列线图预测乙型肝炎相关肝硬化肝细胞癌患者个体预后。
BMC Surg. 2022 Sep 13;22(1):339. doi: 10.1186/s12893-022-01789-4.
肝移植治疗肝细胞癌:马拉蒂亚经验及扩大标准的建议。
J Gastrointest Cancer. 2020 Sep;51(3):998-1005. doi: 10.1007/s12029-020-00424-w.
4
A global view of hepatocellular carcinoma: trends, risk, prevention and management.全球视角下的肝细胞癌:趋势、风险、预防与管理。
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22.
5
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.DNA 甲基化分析预测脑膜瘤复发风险:建立并验证列线图以优化临床管理。
Neuro Oncol. 2019 Jul 11;21(7):901-910. doi: 10.1093/neuonc/noz061.
6
Development and Validation of a Nomogram to Predict Lymphedema After Axillary Surgery and Radiation Therapy in Women With Breast Cancer From the NCIC CTG MA.20 Randomized Trial.基于 NCIC CTG MA.20 随机试验的女性乳腺癌腋窝手术后和放疗后淋巴水肿预测列线图的开发和验证。
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):165-173. doi: 10.1016/j.ijrobp.2019.05.002. Epub 2019 May 11.
7
A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study.一种用于预测 R0 肝切除术后伴有门静脉癌栓的肝细胞癌早期术后复发的列线图:一项大规模、多中心研究。
Eur J Surg Oncol. 2019 Sep;45(9):1644-1651. doi: 10.1016/j.ejso.2019.03.043. Epub 2019 Apr 3.
8
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.一种包含中性粒细胞与淋巴细胞比值的新列线图的开发,用于预测接受经动脉化疗栓塞的肝细胞癌患者的生存情况。
Cancers (Basel). 2019 Apr 10;11(4):509. doi: 10.3390/cancers11040509.
9
Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center.新型微血管侵犯肝细胞癌患者预后列线图:单中心经验。
Gut Liver. 2019 Nov 15;13(6):669-682. doi: 10.5009/gnl18489.
10
Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis.术后辅助经肝动脉化疗栓塞术改善伴有肝静脉侵犯的肝细胞癌患者预后:倾向评分匹配分析。
Ann Surg Oncol. 2019 May;26(5):1465-1473. doi: 10.1245/s10434-019-07223-z. Epub 2019 Feb 14.